EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity

Yuankun Zhang iD, Qingxiao Song, Kaniel Cassady, Michael Lee, Haidong Tang iD, Moqian Zheng, Bixin Wang, Dustin E Schones iD, Yang-Xin Fu iD, Arthur D Riggs, Paul J Martin iD, Ru Feng und 1 weitere

Proceedings of the National Academy of Sciences · 18.04.2023 · 120 (16)

DOI: 10.1073/pnas.2205085120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.04.2023. Verfasst von Yuankun Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, B7-H1 Antigen. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PD-L1 has two receptors: PD-1 and CD80. Previous reports assumed that PD-L1 and CD80 interacted in trans, but recent reports showed that only cis PD-L1/CD80 interactions existed, and prevention of cis PD-L1/CD80 interactions on antigen-presenting cells (APCs) reduced antitumor immunity via augmenting PD-L1/PD-1 and CD80/CTLA4 interactions between T and APCs. Here, using tumor-bearing mice capable of cis and trans or trans only PD-L1/CD80 interactions, we show that trans PD-L1/CD80 interactions do exist between tumor and T cells, and the effects of trans PD-L1/CD80 interactions require tumor cell expression of MHC-I and T cell expression of CD28. The blockade of PD-L1/CD80 interactions in mice with both cis and trans interactions or with only trans interactions augments antitumor immunity by expanding IFN-γ–producing CD8 + T cells and IFN-γ–dependent NOS2-expressing tumor-associated macrophages. Our studies indicate that although cis and trans PD-L1/CD80 interactions may have opposite effects on antitumor immunity, the net effect of blocking PD-L1/CD80 interactions in vivo augments CD8 + T cell-mediated antitumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesB7-H1 AntigenMiceAnimalsProgrammed Cell Death 1 ReceptorLymphocyte ActivationB7-1 AntigenCell Adhesion Molecules

Stichwörter der Autor:innen

CD8+ T cellsCD80PD-L1PD-L1 interaction with CD80tumor immunity

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 ReceptorB7-1 AntigenCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope Medical Center, Duarte, CA 91010.
  • Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA 91010.
  • Fujian Medical University Center of Translational Hematology, Fujian Institute of Hematology, and Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Irell & Manella Graduate School of Biological Sciences, City of Hope National Medical Center, Duarte, CA 91010.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390.

ORCID-Profile: Yuankun Zhang, Haidong Tang, Dustin E Schones, Yang-Xin Fu, Paul J Martin

Förderung

  • NCI NIH HHS

Zitieren

APA

Zhang, Y., Song, Q., Cassady, K., Lee, M., Tang, H., Zheng, M., Wang, B., Schones, D. E., Fu, Y. X., Riggs, A. D., Martin, P. J., Feng, R., & Zeng, D. (2023). Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity. Proceedings of the National Academy of Sciences, 120(16). https://doi.org/10.1073/pnas.2205085120

Vancouver

Zhang Y, Song Q, Cassady K, Lee M, Tang H, Zheng M, et al. Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity. Proceedings of the National Academy of Sciences. 2023;120(16). doi:10.1073/pnas.2205085120

BibTeX
@article{Zhang2023,
  author = {Zhang, Yuankun and Song, Qingxiao and Cassady, Kaniel and Lee, Michael and Tang, Haidong and Zheng, Moqian and Wang, Bixin and Schones, Dustin E and Fu, Yang-Xin and Riggs, Arthur D and Martin, Paul J and Feng, Ru and Zeng, Defu},
  title = {Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {16},
  doi = {10.1073/pnas.2205085120}
}
Kostenlos starten →